Abstract:Traditional medicine (TM) plays an important role in the healthcare system and is increasingly used worldwide for managing various chronic diseases and promoting well-being. Although huge progresses have been achieved to reveal major compounds in well-known botanical drugs, such as Salvia miltiorrhiza Bunge, the identification of major active constituents remains extremely challenging due to the complexity of chemical composition and the elusive mechanisms of action. One major barrier to solving such problems is the lack of feasible techniques and strategies to distinguish those active compounds from those which make no or only a minor contribution to the activity of TM. Often ubiquitous or widely distributed compounds are then claimed to be “actives” for major disease conditions. Moreover, it is difficult to judge whether certain components or compounds identified by a specific cellular model or target-based assays can exert a pharmacological effect in vivo in the context of biological network or in a real-life clinical setting. Therefore, it is time to dedicate greater efforts in either improving the capability of bioassays or developing novel paradigms to refresh our toolbox for dissecting TMs. The aim of this research topic is to improve the quality of such studies, accelerate the pace of screening and identification of active compounds from TMs, and to facilitate the expansion of screening assays from cellular tissue levels to organs and in vivomodels. In the past 3 decades, bioactivity-guided screening has become a mainstream workflow for lead discovery from TMs. With the aid of modern analytical approaches such as LC-MS, GC-MS, and NMR, it allows us to identify multiple constituents in active components found by phenotypes or target-based assays. However, synergistic effects among multiple compounds of TMs are difficult to recognize during conventional phytochemical isolation, which requires repeated purification steps to obtain a single compound from mixtures of TM. In this research topic, four articles are dedicated to develop novel analytical or preparing approaches to uncover the chemical composition of TM. Nie et al. used the emerging microscopic mass spectrometry imaging technique to reveal the distribution of phytochemicals in the dried root of Isatis tinctoria L. With the aid of the chemometric method, different samples from four habitats were successfully clustered. Chang YX and co-workers Yang et al. established a rapid high throughput vibration and vortex-assisted matrix solid phase dispersion method for simultaneous extraction of four isoflavones from Glycine max (L.) Merr. With satisfied recovery and a linear range, the approach was applied in the quality control of SSP. Edited and reviewed by: Michael Heinrich, University College London, United Kingdom

Colorectal cancer early detection program integrated in practice of family physicians.

Editorial: Dissecting Traditional Medicine Via Chemical and Biochemical Techniques: Advanced Analytics and Novel Paradigms

Immobilized magnetic beads-based multi-target affinity selection coupled with HPLC-MS for screening active compounds from traditional Chinese medicine and natural products.

Recent advances in screening active components from natural products based on bioaffinity techniques

Chemometric‐based drug discovery approaches from natural origins using hyphenated chromatographic techniques

Metabolite-protein interactions: Native mass spectrometry and collision induced affinity selection mass spectrometry in natural product screening

Current and emerging tools and strategies for the identification of bioactive natural products in complex mixtures

Advanced high-resolution chromatographic strategies for efficient isolation of natural products from complex biological matrices: from metabolite profiling to pure chemical entities

Completing the Screen: Biochemical Cascades to Prioritize HTS Output

Recent advances in bio-affinity chromatography for screening bioactive compounds from natural products

High Throughput Screening of Chromatographic Phases for Rapid Process Development

Trends using biological target-based assays for drug detection in complex sample matrices

High-Throughput Mining of Novel Compounds from Known Microbes: A Boost to Natural Product Screening

High throughput screening of physicochemical properties and in vitro ADME profiling in drug discovery

Orthogonal Hyphenation of Planar and Liquid Chromatography for Mass Spectrometry of Biomarkers out of the Bioassay Matrix (NP-HPTLC-UV/vis/FLD-Bioassay-RP/IEX-HPLC-UV/vis-ESI-MS)

High Throughput, Label-free Screening Small Molecule Compound Libraries for Protein-Ligands Using Combination of Small Molecule Microarrays and a Special Ellipsometry-based Optical Scanner.

Screening and identification of novel biologically active natural compounds

Analytical strategies for identifying drug metabolites

New developments and emerging trends in high-throughput screening methods for lead compound identification

Expanding Chemical Frontiers: Approaches for Generating Diverse and Bioactive Natural Product‐Like Compounds Libraries from Extracts

Virtual Screening on Natural Products for Discovering Active Compounds and Target Information